메뉴 건너뛰기




Volumn 13, Issue 11, 2014, Pages 2595-2606

Development of targeted near-infrared imaging agents for prostate cancer

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN 1 CY5.5; PROSTATE SPECIFIC MEMBRANE ANTIGEN 1 IRDY800; UNCLASSIFIED DRUG; CONTRAST MEDIUM; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; MEMBRANE ANTIGEN;

EID: 84918805363     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-14-0422     Document Type: Article
Times cited : (91)

References (50)
  • 2
    • 0029037784 scopus 로고
    • Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy
    • Theiss M, Wirth MP, Manseck A, Frohmuller HG. Prognostic significance of capsular invasion and capsular penetration in patients with clinically localized prostate cancer undergoing radical prostatectomy. Prostate 1995;27:13-7.
    • (1995) Prostate , vol.27 , pp. 13-17
    • Theiss, M.1    Wirth, M.P.2    Manseck, A.3    Frohmuller, H.G.4
  • 3
    • 84879459843 scopus 로고    scopus 로고
    • Positive margins after radical prostatectomy: Implications for failure and role of adjuvant treatment
    • Swanson GP, Lerner SP. Positive margins after radical prostatectomy: implications for failure and role of adjuvant treatment. Urol Oncol 2013;31:531-41.
    • (2013) Urol Oncol , vol.31 , pp. 531-541
    • Swanson, G.P.1    Lerner, S.P.2
  • 4
    • 77951880385 scopus 로고    scopus 로고
    • Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality
    • Wright JL, Dalkin BL, True LD, Ellis WJ, Stanford JL, Lange PH, et al. Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol 2010;183:2213-8.
    • (2010) J Urol , vol.183 , pp. 2213-2218
    • Wright, J.L.1    Dalkin, B.L.2    True, L.D.3    Ellis, W.J.4    Stanford, J.L.5    Lange, P.H.6
  • 5
    • 0023547004 scopus 로고
    • Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients
    • Horoszewicz JS, Kawinski E, Murphy GP. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res 1987;7:927-35.
    • (1987) Anticancer Res , vol.7 , pp. 927-935
    • Horoszewicz, J.S.1    Kawinski, E.2    Murphy, G.P.3
  • 6
    • 0028631034 scopus 로고
    • Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: Comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays
    • Israeli RS, Miller WH Jr, Su SL, Powell CT, Fair WR, Samadi DS, et al. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 1994;54:6306-10.
    • (1994) Cancer Res , vol.54 , pp. 6306-6310
    • Israeli, R.S.1    Miller, W.H.2    Su, S.L.3    Powell, C.T.4    Fair, W.R.5    Samadi, D.S.6
  • 7
    • 0034797419 scopus 로고    scopus 로고
    • A unique folate hydrolase, prostate-specific membrane antigen (PSMA): A target for immunotherapy?
    • Tasch J, Gong M, Sadelain M, Heston WD. A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy? Crit Rev Immunol 2001;21:249-61.
    • (2001) Crit Rev Immunol , vol.21 , pp. 249-261
    • Tasch, J.1    Gong, M.2    Sadelain, M.3    Heston, W.D.4
  • 8
    • 68949116384 scopus 로고    scopus 로고
    • Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis
    • Mannweiler S, Amersdorfer P, Trajanoski S, Terrett JA, King D, Mehes G. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res 2009;15:167-72.
    • (2009) Pathol Oncol Res , vol.15 , pp. 167-172
    • Mannweiler, S.1    Amersdorfer, P.2    Trajanoski, S.3    Terrett, J.A.4    King, D.5    Mehes, G.6
  • 9
    • 0029154151 scopus 로고
    • Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids
    • Troyer JK, Beckett ML, Wright GL Jr. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J Cancer 1995;62:552-8.
    • (1995) Int J Cancer , vol.62 , pp. 552-558
    • Troyer, J.K.1    Beckett, M.L.2    Wright, G.L.3
  • 10
    • 0346333234 scopus 로고    scopus 로고
    • Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer
    • Ross JS, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, Gray K, et al. Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin Cancer Res 2003;9:6357-62.
    • (2003) Clin Cancer Res , vol.9 , pp. 6357-6362
    • Ross, J.S.1    Sheehan, C.E.2    Fisher, H.A.3    Kaufman, R.P.4    Kaur, P.5    Gray, K.6
  • 12
    • 0033168844 scopus 로고    scopus 로고
    • Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature
    • Chang SS, Reuter VE, Heston WD, Bander NH, Grauer LS, Gaudin PB. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. Cancer Res 1999;59:3192-8.
    • (1999) Cancer Res , vol.59 , pp. 3192-3198
    • Chang, S.S.1    Reuter, V.E.2    Heston, W.D.3    Bander, N.H.4    Grauer, L.S.5    Gaudin, P.B.6
  • 14
    • 0025912619 scopus 로고
    • Immunoscintigraphy of prostatic cancer: Preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356)
    • Wynant GE, Murphy GP, Horoszewicz JS, Neal CE, Collier BD, Mitchell E, et al. Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356). Prostate 1991;18:229-41.
    • (1991) Prostate , vol.18 , pp. 229-241
    • Wynant, G.E.1    Murphy, G.P.2    Horoszewicz, J.S.3    Neal, C.E.4    Collier, B.D.5    Mitchell, E.6
  • 15
    • 33645765986 scopus 로고    scopus 로고
    • Technology insight: Monoclonal antibody imaging of prostate cancer
    • Bander NH. Technology insight: monoclonal antibody imaging of prostate cancer. Nat Clin Pract Urol 2006;3:216-25.
    • (2006) Nat Clin Pract Urol , vol.3 , pp. 216-225
    • Bander, N.H.1
  • 16
    • 22044451179 scopus 로고    scopus 로고
    • Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer
    • Bander NH, Milowsky MI, Nanus DM, Kostakoglu L, Vallabhajosula S, Goldsmith SJ. Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. J Clin Oncol 2005;23:4591-601.
    • (2005) J Clin Oncol , vol.23 , pp. 4591-4601
    • Bander, N.H.1    Milowsky, M.I.2    Nanus, D.M.3    Kostakoglu, L.4    Vallabhajosula, S.5    Goldsmith, S.J.6
  • 17
    • 0141919750 scopus 로고    scopus 로고
    • Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen
    • Bander NH, Trabulsi EJ, Kostakoglu L, Yao D, Vallabhajosula S, Smith-Jones P, et al. Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen. J Urol 2003;170:1717-21.
    • (2003) J Urol , vol.170 , pp. 1717-1721
    • Bander, N.H.1    Trabulsi, E.J.2    Kostakoglu, L.3    Yao, D.4    Vallabhajosula, S.5    Smith-Jones, P.6
  • 18
    • 84899103424 scopus 로고    scopus 로고
    • A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy
    • Osborne JR, Green DA, Spratt DE, Fareedy SB, Robinson BD, Beattie BJ, et al. A prospective pilot study of (89)Zr-J591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy. J Urol 2013;191:1439-45.
    • (2013) J Urol , vol.191 , pp. 1439-1445
    • Osborne, J.R.1    Green, D.A.2    Spratt, D.E.3    Fareedy, S.B.4    Robinson, B.D.5    Beattie, B.J.6
  • 19
    • 84884536175 scopus 로고    scopus 로고
    • Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer
    • Tagawa ST, Milowsky MI, Morris M, Vallabhajosula S, Christos P, Akhtar NH, et al. Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res 2013;19:5182-91.
    • (2013) Clin Cancer Res , vol.19 , pp. 5182-5191
    • Tagawa, S.T.1    Milowsky, M.I.2    Morris, M.3    Vallabhajosula, S.4    Christos, P.5    Akhtar, N.H.6
  • 20
    • 31344447699 scopus 로고    scopus 로고
    • High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen
    • Humblet V, Lapidus R, Williams LR, Tsukamoto T, Rojas C, Majer P, et al. High-affinity near-infrared fluorescent small-molecule contrast agents for in vivo imaging of prostate-specific membrane antigen. Mol Imaging 2005;4:448-62.
    • (2005) Mol Imaging , vol.4 , pp. 448-462
    • Humblet, V.1    Lapidus, R.2    Williams, L.R.3    Tsukamoto, T.4    Rojas, C.5    Majer, P.6
  • 21
    • 49449111732 scopus 로고    scopus 로고
    • Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)
    • Banerjee SR, Foss CA, Castanares M, Mease RC, Byun Y, Fox JJ, et al. Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA). J Med Chem 2008;51:4504-17.
    • (2008) J Med Chem , vol.51 , pp. 4504-4517
    • Banerjee, S.R.1    Foss, C.A.2    Castanares, M.3    Mease, R.C.4    Byun, Y.5    Fox, J.J.6
  • 22
    • 77954691424 scopus 로고    scopus 로고
    • 68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer
    • Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Green G, Fox JJ, et al. 68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer. J Med Chem 2010;53:5333-41.
    • (2010) J Med Chem , vol.53 , pp. 5333-5341
    • Banerjee, S.R.1    Pullambhatla, M.2    Byun, Y.3    Nimmagadda, S.4    Green, G.5    Fox, J.J.6
  • 24
    • 58149098403 scopus 로고    scopus 로고
    • Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer
    • Chen Y, Foss CA, Byun Y, Byun Y, Pullambhatla M, Mease RC, et al. Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer. J Med Chem 2008;51:7933-43.
    • (2008) J Med Chem , vol.51 , pp. 7933-7943
    • Chen, Y.1    Foss, C.A.2    Byun, Y.3    Byun, Y.4    Pullambhatla, M.5    Mease, R.C.6
  • 25
    • 20344374435 scopus 로고    scopus 로고
    • Radiolabeled small-molecule ligands for prostate-specific membrane antigen: In vivo imaging in experimental models of prostate cancer
    • Foss CA, Mease RC, Fan H, Wang Y, Ravert HT, Dannals RF, et al. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res 2005;11:4022-8.
    • (2005) Clin Cancer Res , vol.11 , pp. 4022-4028
    • Foss, C.A.1    Mease, R.C.2    Fan, H.3    Wang, Y.4    Ravert, H.T.5    Dannals, R.F.6
  • 26
    • 79960301987 scopus 로고    scopus 로고
    • 123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy
    • Hillier SM, Kern AM, Maresca KP, Wang Y, Ravert HT, Dannals RF, et al. 123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy. J Nucl Med 2011;52:1087-93.
    • (2011) J Nucl Med , vol.52 , pp. 1087-1093
    • Hillier, S.M.1    Kern, A.M.2    Maresca, K.P.3    Wang, Y.4    Ravert, H.T.5    Dannals, R.F.6
  • 27
    • 70149094319 scopus 로고    scopus 로고
    • Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer
    • Hillier SM, Maresca KP, Femia FJ, Marquis JC, Foss CA, Nguyen N, et al. Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer. Cancer Res 2009;69:6932-40.
    • (2009) Cancer Res , vol.69 , pp. 6932-6940
    • Hillier, S.M.1    Maresca, K.P.2    Femia, F.J.3    Marquis, J.C.4    Foss, C.A.5    Nguyen, N.6
  • 28
    • 84881417445 scopus 로고    scopus 로고
    • 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer
    • Hillier SM, Maresca KP, Lu G, Merkin RD, Marquis JC, Zimmerman CN, et al. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer. J Nucl Med 2013;54:1369-76.
    • (2013) J Nucl Med , vol.54 , pp. 1369-1376
    • Hillier, S.M.1    Maresca, K.P.2    Lu, G.3    Merkin, R.D.4    Marquis, J.C.5    Zimmerman, C.N.6
  • 30
    • 84871268152 scopus 로고    scopus 로고
    • Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen
    • Chen Y, Pullambhatla M, Banerjee SR, Byun Y, Stathis M, Rojas C, et al. Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen. Bioconjug Chem 2009;23:2377-85.
    • (2009) Bioconjug Chem , vol.23 , pp. 2377-2385
    • Chen, Y.1    Pullambhatla, M.2    Banerjee, S.R.3    Byun, Y.4    Stathis, M.5    Rojas, C.6
  • 31
    • 84870340190 scopus 로고    scopus 로고
    • Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer
    • Cho SY, Gage KL, Mease RC, Senthamizhchelvan S, Holt DP, Jeffrey-Kwanisai A, et al. Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer. J Nucl Med 2012;53:1883-91.
    • (2012) J Nucl Med , vol.53 , pp. 1883-1891
    • Cho, S.Y.1    Gage, K.L.2    Mease, R.C.3    Senthamizhchelvan, S.4    Holt, D.P.5    Jeffrey-Kwanisai, A.6
  • 32
    • 49449089475 scopus 로고    scopus 로고
    • N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: A new imaging probe for prostate cancer
    • Mease RC, Dusich CL, Foss CA, Senthamizhchelvan S, Holt DP, Jeffrey-Kwanisai A, et al. N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer. Clin Cancer Res 2008;14:3036-43.
    • (2008) Clin Cancer Res , vol.14 , pp. 3036-3043
    • Mease, R.C.1    Dusich, C.L.2    Foss, C.A.3    Senthamizhchelvan, S.4    Holt, D.P.5    Jeffrey-Kwanisai, A.6
  • 33
    • 84874820819 scopus 로고    scopus 로고
    • First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer
    • Barrett JA, Coleman RE, Goldsmith SJ, Vallabhajosula S, Petry NA, Cho S, et al. First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer. J Nucl Med 2013;54:380-7.
    • (2013) J Nucl Med , vol.54 , pp. 380-387
    • Barrett, J.A.1    Coleman, R.E.2    Goldsmith, S.J.3    Vallabhajosula, S.4    Petry, N.A.5    Cho, S.6
  • 34
    • 84898829722 scopus 로고    scopus 로고
    • Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker
    • Huang SS, Wang X, Zhang Y, Doke A, Difilippo FP, Heston WD. Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker. Prostate 2014;74:702-13.
    • (2014) Prostate , vol.74 , pp. 702-713
    • Huang, S.S.1    Wang, X.2    Zhang, Y.3    Doke, A.4    Difilippo, F.P.5    Heston, W.D.6
  • 35
    • 84859806938 scopus 로고    scopus 로고
    • Structure-activity relationships of 2′,5′-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists
    • Wang X, Tian H, Lee Z, Heston WD. Structure-activity relationships of 2′,5′-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists. Nucleosides Nucleotides Nucleic Acids 2012;31:432-44.
    • (2012) Nucleosides Nucleotides Nucleic Acids , vol.31 , pp. 432-444
    • Wang, X.1    Tian, H.2    Lee, Z.3    Heston, W.D.4
  • 36
    • 84865050506 scopus 로고    scopus 로고
    • A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo
    • Petty A, Myshkin E, Qin H, Guo H, Miao H, Tochtrop GP, et al. A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo. PLoS ONE 2012;7:e42120.
    • (2012) PLoS ONE , vol.7 , pp. e42120
    • Petty, A.1    Myshkin, E.2    Qin, H.3    Guo, H.4    Miao, H.5    Tochtrop, G.P.6
  • 38
    • 33947541693 scopus 로고    scopus 로고
    • Human glutamate carboxypeptidase II inhibition: Structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA
    • Mesters JR, Henning K, Hilgenfeld R. Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA. Acta Crystallogr D Biol Crystallogr 2007;63:508-13.
    • (2007) Acta Crystallogr D Biol Crystallogr , vol.63 , pp. 508-513
    • Mesters, J.R.1    Henning, K.2    Hilgenfeld, R.3
  • 39
    • 68749087539 scopus 로고    scopus 로고
    • Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III
    • Hlouchova K, Barinka C, Konvalinka J, Lubkowski J. Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III. FEBS J 2009;276:4448-62.
    • (2009) FEBS J , vol.276 , pp. 4448-4462
    • Hlouchova, K.1    Barinka, C.2    Konvalinka, J.3    Lubkowski, J.4
  • 40
    • 3843113671 scopus 로고    scopus 로고
    • Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
    • Ghosh A, Heston WD. Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem 2004;91:528-39.
    • (2004) J Cell Biochem , vol.91 , pp. 528-539
    • Ghosh, A.1    Heston, W.D.2
  • 41
    • 0345306595 scopus 로고    scopus 로고
    • A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen
    • Rajasekaran SA, Anilkumar G, Oshima E, Bowie JU, Liu H, Heston W, et al. A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen. Mol Biol Cell 2003;14:4835-45.
    • (2003) Mol Biol Cell , vol.14 , pp. 4835-4845
    • Rajasekaran, S.A.1    Anilkumar, G.2    Oshima, E.3    Bowie, J.U.4    Liu, H.5    Heston, W.6
  • 42
    • 78149285690 scopus 로고    scopus 로고
    • A targeted low molecular weight near-infrared fluorescent probe for prostate cancer
    • Liu T, Wu LY, Hopkins MR, Choi JK, Berkman CE. A targeted low molecular weight near-infrared fluorescent probe for prostate cancer. Bioorg Med Chem Lett 2010;20:7124-6.
    • (2010) Bioorg Med Chem Lett , vol.20 , pp. 7124-7126
    • Liu, T.1    Wu, L.Y.2    Hopkins, M.R.3    Choi, J.K.4    Berkman, C.E.5
  • 43
    • 80051777429 scopus 로고    scopus 로고
    • Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate
    • Nakajima T, Mitsunaga M, Bander NH, Heston WD, Choyke PL, Kobayashi H. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate. Bioconjug Chem 2011;22:1700-5.
    • (2011) Bioconjug Chem , vol.22 , pp. 1700-1705
    • Nakajima, T.1    Mitsunaga, M.2    Bander, N.H.3    Heston, W.D.4    Choyke, P.L.5    Kobayashi, H.6
  • 44
    • 67349230887 scopus 로고    scopus 로고
    • Intraoperative radioguidance with a portable gamma camera: A novel technique for laparoscopic sentinel node localisation in urological malignancies
    • Vermeeren L, Valdes Olmos RA, Meinhardt W, Bex A, van der Poel HG, Vogel WV, et al. Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies. Eur J Nucl Med Mol Imaging 2009;36:1029-36.
    • (2009) Eur J Nucl Med Mol Imaging , vol.36 , pp. 1029-1036
    • Vermeeren, L.1    Valdes Olmos, R.A.2    Meinhardt, W.3    Bex, A.4    Van Der Poel, H.G.5    Vogel, W.V.6
  • 46
    • 0030065584 scopus 로고    scopus 로고
    • Enhanced optical imaging of human gliomas and tumor margins
    • Haglund MM, Berger MS, Hochman DW. Enhanced optical imaging of human gliomas and tumor margins. Neurosurgery 1996;38:308-17.
    • (1996) Neurosurgery , vol.38 , pp. 308-317
    • Haglund, M.M.1    Berger, M.S.2    Hochman, D.W.3
  • 47
    • 77957977603 scopus 로고    scopus 로고
    • Multimodality intraoperative MRI for brain tumor surgery
    • Colen RR, Kekhia H, Jolesz FA. Multimodality intraoperative MRI for brain tumor surgery. Expert Rev Neurother 2010;10:1545-58.
    • (2010) Expert Rev Neurother , vol.10 , pp. 1545-1558
    • Colen, R.R.1    Kekhia, H.2    Jolesz, F.A.3
  • 48
    • 80053989452 scopus 로고    scopus 로고
    • Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: First in-human results
    • van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med 2011;17:1315-9.
    • (2011) Nat Med , vol.17 , pp. 1315-1319
    • Van Dam, G.M.1    Themelis, G.2    Crane, L.M.3    Harlaar, N.J.4    Pleijhuis, R.G.5    Kelder, W.6
  • 49
    • 0031972670 scopus 로고    scopus 로고
    • Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study
    • Talcott JA, Rieker P, Clark JA, Weeks JC, Beard CJ, Wishnow KI, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol 1998;16:275-83.
    • (1998) J Clin Oncol , vol.16 , pp. 275-283
    • Talcott, J.A.1    Rieker, P.2    Clark, J.A.3    Weeks, J.C.4    Beard, C.J.5    Wishnow, K.I.6
  • 50
    • 84878619701 scopus 로고    scopus 로고
    • Robotic retroperitoneal transvaginal natural orifice translumenal endoscopic surgery (NOTES) nephrectomy: Feasibility study in a cadaver model
    • Laydner H, Autorino R, Isac W, Khalifeh A, Panumatrassamee K, Kassab A, et al. Robotic retroperitoneal transvaginal natural orifice translumenal endoscopic surgery (NOTES) nephrectomy: feasibility study in a cadaver model. Urology 2012;81:1232-7.
    • (2012) Urology , vol.81 , pp. 1232-1237
    • Laydner, H.1    Autorino, R.2    Isac, W.3    Khalifeh, A.4    Panumatrassamee, K.5    Kassab, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.